Bryan Tracy is the CEO and co-founder of Superbrewed Food, Inc.  Prior to this, he co-founded and led Elcriton Inc. and White Dog Labs, and briefly worked at Novozymes (now called Novonesis). Bryan and Superbrewed Food are pioneering the field of natural biotechnology. Under Bryan’s technical leadership, Superbrewed Food has discovered, scaled, patented, and commercialized the use of natural microorganisms to produce better foods and materials for a healthier, abundant and more affordable future. Most notably, Superbrewed has brought to market the first ever bacteria biomass protein ingredient – Postbiotic Cultured Protein. Postbiotic Cultured Protein exceeds all protein ingredients by delivering complete protein and postbiotic health benefits, in addition to being non-GMO, animal-free, allergen-free, and highly functional. Under Bryan’s business leadership, Superbrewed has forged partnerships with leaders in the value chain of food innovation. Superbrewed is partnering with Bel Group, a global CPG leader in cheeses and snacks, to develop a portfolio of solutions for iconic consumer brands. Superbrewed is partnering with Döhler, a global leader in ingredient solutions and natural ingredient manufacturing, to produce the first commercial volumes of Postbiotic Cultured Protein. Lastly, Bryan has cultivated a partnership with Fonterra, the third largest dairy-cooperative in the world, to grow the value and market reach of Postbiotic Cultured Protein, and solve a supply chain bottleneck for Fonterra. Bryan is also passionate about public service. He is on the board of the Forum to Advance Minorities in Engineering (FAME), one of the oldest non-profits in the US that serves underrepresented populations pursue STEM careers.  He is also on the non-profit board of the Delaware Sustainable Chemistry Alliance, which spearheaded the MACH2 initiative – a $730 million collaboration in Delaware, Pennsylvania, and Maryland for sustainable hydrogen generation and use. Bryan started his career as a technical expert and continues to have fundamental impact in industrial biotechnology with 16 scientific articles and over 50 granted and pending patents. He received a BS in Chemical and Biomolecular Engineering from North Carolina State University and a PhD in Chemical and Biological Engineering from Northwestern University, where he was a NIH Biotechnology Fellow.